公开(公告)号：KR100405161B1

公开(公告)日：2003-11-12

申请号：KR1020000076298

申请日：2000-12-14

Applicant: 신풍제약주식회사

Inventor： 이성태 ,  한신 ,  박우일 ,  주정철 ,  이철규 ,  김혜선

IPC: A61K9/08

CPC classification number: A61K9/0019 ,  A61K31/192 ,  A61K47/02

Abstract: Disclosed is a formulation for intramuscular injection containingloxoprofen or a pharmaceutically acceptable salt thereof, having an excellent anti-inflammatory analgesic effect, as an active ingredient.

Abstract translation: 本发明公开了含有洛索洛芬或其药学上可接受的盐作为有效成分，具有优异的消炎镇痛作用的肌内注射用制剂。

公开(公告)号：KR1020020046407A

公开(公告)日：2002-06-21

申请号：KR1020000076298

申请日：2000-12-14

Applicant: 신풍제약주식회사

Inventor： 이성태 ,  한신 ,  박우일 ,  주정철 ,  이철규 ,  김혜선

IPC: A61K9/08

CPC classification number: A61K9/0019 ,  A61K31/192 ,  A61K47/02

Abstract: PURPOSE: Provided is a pharmaceutical composition for intramuscular injection containing loxoprofen having excellent anti-inflammatory effects, as an active ingredient, and its pharmaceutically acceptable salts. CONSTITUTION: The pharmaceutical composition for intramuscular injection contains loxoprofen represented by the formula(1) or its pharmaceutically acceptable salts. It is manufactured by dissolving loxoprofen or its pharmaceutically acceptable salt, a stabilizing agent or solution adjuvant in water for injection then sterilizing it.

Abstract translation: 目的：提供含有作为活性成分的优良抗炎作用的洛索丙芬及其药学上可接受的盐的肌内注射用药物组合物。 构成：用于肌内注射的药物组合物含有由式（1）表示的洛索洛芬或其药学上可接受的盐。 它是通过将洛索洛芬或其药学上可接受的盐，稳定剂或溶液佐剂溶解在水中，然后对其进行消毒而制造的。